Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
26.00    0.25 (0.97%)
Bid:
25.50
Ask:
26.50
Spread: 1.00 (3.922%)
Market Cap: £130.91m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

New Royalty Agreement

2 Aug 2021 07:00

RNS Number : 1582H
Duke Royalty Limited
02 August 2021
 

2 August 2021

 

Duke Royalty Limited

 

("Duke Royalty" or "Duke")

 

New Royalty Agreement with Engineering, Procurement and Construction Services Business

 

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce that it has further broadened its revenue base by entering into an CA$8.3 million (approximately £4.8 million) royalty financing agreement (the "Financing") with Creō-Tech Industrial Group Inc. ("Creō-Tech").

 

Creō-Tech is a Canadian holding company that has been set up to acquire businesses that provide engineering, procurement and construction ("EPC") services in commercial and industrial settings. In connection with the Financing, Creō-Tech has acquired two businesses, Axial Inc. ("Axial" and together with its subsidiaries "Axial Group") and Silhouette Enclosures Ltd. ("Silhouette"). Axial is a provider of industrial automation and engineering services based in Calgary, Alberta, and Silhouette specialises in the design and fabrication of custom industrial enclosures and is based in Abbotsford, British Columbia.

 

Highlights:

 

· Duke has agreed a total funding commitment of up to CA$20 million (approximately £11.6 million) to support Creō-Tech's buy-and-build strategy to acquire profitable EPC businesses across Canada

· CA$8.3 million initial drawdown to facilitate the acquisitions of Silhouette and Axial, both of which have a longstanding operations and predictable revenue streams

· Initial cash yield of 13.2% per annum via monthly payments, which commence immediately

· 30-year secured financing, with distributions to be adjusted annually to reflect Creō-Tech's consolidated revenue growth, on typical Duke terms

· As part of the financing, Duke will take an initial 18.75% equity stake in Creō-Tech.

 

Neil Johnson, CEO of Duke Royalty, said:

 

"Since our successful fundraise in April, Duke Royalty has entered into three new partnerships, building on the record normalised cash revenue that we recently reported for the first quarter of our current financial year. This partnership is also Duke's first significant deal in North America, diversifying our geographic presence, as well as our revenue base. Duke's investment in Creō-Tech is consistent with our investment strategy in that it supports a buy-and-build model focused on the acquisition of long standing, profitable companies in an attractive and fragmented market with potential for additional follow-on investments.

 

"Duke is backing a strong management team in Creō-Tech. With significant industry experience they will look to identify and acquire profitable, private businesses, whilst driving growth and profitability across the group by realising synergies and pooling back-end functions."

 

Dirk Maritz, CEO of Creō-Tech, said:

 

"Duke's investment solution is a great fit for the Creō-Tech group of companies. It has provided a platform for Creō-Tech's growth both organically and through future acquisitions. We are excited to be partnered with Duke to execute on our clearly defined plan to create a multi-disciplinary, high quality EPC firm."

 

Further information regarding Creō-Tech:

 

Creō-Tech is a privately-owned group of companies offering innovative multi-disciplinary engineering & manufacturing applications in energy, power generation, material handling, mining, manufacturing & processing, telecommunications and utilities markets. In addition to its reputable manufacturing operation, Creō-Tech offers a full complement of services to the North American industrial mid-market, including structural, electro-mechanical, automation and technical support solutions. Creō-Tech offers a competitive advantage through customised approaches and innovative solutions, to meet client's needs. To learn more, visit creotechgroup.com.

 

Axial Group

 

Axial Group is a boutique, multi-disciplinary engineering firm offering clients EPC services in a wide variety of industries. Established in Calgary, Alberta in 1997, Axial Group has comprehensive industry expertise and technological capabilities, delivering innovative structural and electro-mechanical engineering, industrial automation and industrial IT solutions, in both new construction and retrofit environments. Axial Group has extensive global expertise, having delivered and managed projects both domestically and internationally.

 

Silhouette

 

Silhouette is a specialised leader in custom design and fabrication of industrial enclosures and control rooms. Silhouette, located near Vancouver, Canada with an 18-year history, works directly with its clients to customize structural and electro-mechanical designs, develop innovative acoustic and vibration solutions, and manufacture high-quality products. The company supplies products worldwide, with a primary focus in the Telecommunications, Utilities, Marine & Port, Material Handling, and customers in harsh or remote environments.

 

About the Financing

 

Duke has provided an initial investment of CA$8.3 million to finance Creō-Tech's first two acquisitions, Axial Group and Silhouette, with a total potential investment of up to CA$20.0 million to fund future acquisitions. As part of the financing, Duke will take an initial 18.75% equity stake in Creō-Tech. Future tranches of capital are planned at Duke's sole discretion.

 

The terms of the Financing are in line with Duke's typical investment criteria. The Financing is provided through a combination of a secured loan and preference shares and Duke will be entitled to monthly distributions (the "Distribution") beginning in August 2021.

 

In line with Duke's other investments, and reflective of the participating nature of Duke's business model, the Distribution will be adjusted annually based on the percentage change in Creō-Tech's total combined gross revenues for the 12 months to 31 December 2022, compared to the prior financial (calendar) year. The first adjustment will occur from 1 January 2023. The annual adjustment in the Distribution will be subject to an agreed collar, in line with Duke's typical terms.

 

The Financing is for a period of 30 years, with the Distribution payable to Duke throughout the duration of this term, unless Creō-Tech utilises an early buyback option which will trigger an early redemption payment to Duke.

 

 

Duke Royalty Portfolio

 

A full list of Duke's current Royalty Partners are now included for reference on our Partners page of our website: www.dukeroyalty.com/partners

 

This announcement contains inside information.

 

***ENDS***

 

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

 

+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

+44 (0) 207 397 8900

 

 

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell / Richard Bicknell / Megan Kovach

+ +44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTUAOBRANUWRAR
Date   Source Headline
28th May 20267:00 amRNSNotice of Results & Investor Presentation
31st Mar 20267:00 amRNSTrading and Operational Update
19th Mar 20267:00 amRNSInterim Dividend and Dividend Declaration
26th Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
18th Dec 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Dec 20257:00 amRNSInterim Financial Results
17th Oct 20257:00 amRNSFollow-On Investment into Step Investments Limited
1st Oct 20257:00 amRNSFollow-On Investment into Integrum Group Holdings
29th Sep 20257:00 amRNSTrading Update
18th Sep 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Aug 202511:17 amRNSResult of Annual General Meeting
1st Aug 20258:08 amRNSDirector/PDMR Dealings
11th Jul 20257:00 amRNSAnnual Report & Notice of Annual General Meeting
25th Jun 20257:00 amRNSFinal Results for the year ended 31 March 2025
19th Jun 20257:00 amRNSInterim Dividend and Dividend Declaration
2nd Jun 20257:00 amRNSFollow-On Investment into Existing Capital Partner
27th May 20257:00 amRNSNotice of Results & Investor Presentation
2nd Apr 20257:00 amRNSFollow-On Investment into Existing Capital Partner
31st Mar 20257:00 amRNSTrading and Operational Update
20th Mar 20257:00 amRNSInterim Dividend and Dividend Declaration
19th Feb 20257:00 amRNSFollow-On Investment into BPVA (Ireland) Limited
30th Dec 20247:00 amRNSTrading and Operational Update
17th Dec 202412:50 pmRNSInterim Dividend and Dividend Declaration
16th Dec 20247:00 amRNSInterim Results for the six months ended 30 Sep 24
4th Dec 20249:40 amRNSDirector/PDMR Shareholding
3rd Dec 202411:34 amRNSResult of General Meeting and Issue of Equity
22nd Nov 20243:38 pmRNSResult of Retail Offer and Broker Option
15th Nov 20247:00 amRNSResult of Placing
14th Nov 20245:02 pmRNSRetail Offer to raise up to £3.0 million
14th Nov 20245:01 pmRNSIssue of Equity
30th Sep 20247:00 amRNSTrading and Operational Update
19th Sep 20247:00 amRNSInterim Dividend and Dividend Declaration
3rd Sep 20247:00 amRNSFollow-On Investment into United Glass Group
1st Aug 20243:16 pmRNSDirector/PDMR Dealings
1st Aug 202411:40 amRNSResult of Annual General Meeting
22nd Jul 20247:00 amRNSFollow-On Investment into Step Investments Limited
15th Jul 20247:00 amRNSAnnual Report & Notice of Annual General Meeting
27th Jun 20247:00 amRNSFinal Results for the year ended 31 March 2024
20th Jun 202411:50 amRNSInterim Dividend and Dividend Declaration
3rd Jun 20247:00 amRNSNotice of Results
17th May 202411:45 amEQSHardman & Co Q&A on Duke Capital (DUKE) | Generating investor returns by uniquely meeting customer needs
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.